Fig. 3From: Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviewsA Frequency that life engagement domains were described as being improved, and B frequency that specific non-calmness terms were described as being improved (top nine), stratified by whether the patient described improvement in calmness (n = 104). aImproved (less or more, depending on the individual). ↑ = more/improvedBack to article page